PillCam Colon 2 Capsule Endoscopy (PCCE) After Incomplete Colonoscopy (PCCE)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2011 by Bethesda Krankenhaus.
Recruitment status was:  Recruiting
Given Imaging Ltd.
Information provided by (Responsible Party):
Bethesda Krankenhaus
ClinicalTrials.gov Identifier:
First received: October 13, 2011
Last updated: November 28, 2011
Last verified: October 2011

Purpose of study:

To evaluate the efficacy of PillCam Colon2 in subjects with an incomplete standard colonoscopy

Study design: 4 centers, prospective, cohort study Number of subjects: 74 subjects

Subject population: Patients that are indicated for colonoscopy, who are suspected or known to suffer from colonic diseases and had an incomplete standard colonoscopy

Control group: None Procedure Duration: Approximately 10-12 hours Duration of Follow up: One week follow up Duration of study: 12 months

Primary objectives: Evaluation of the efficacy of PillCam Colon2 to visualize the colon segment not reached by an incomplete standard colonoscopy Evaluation of distribution of excretion of capsules over time

Condition Phase
Phase 2
Phase 3

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the PillCam Colon Capsule Endoscopy (PCCE) After Incomplete Colonoscopy

Resource links provided by NLM:

Further study details as provided by Bethesda Krankenhaus:

Primary Outcome Measures:
  • Evaluation of the efficacy of PillCam Colon2 to visualize the colon segment not reached by an incomplete standard colonoscopy [ Time Frame: One week follow up ]
    Study endpoint: Number of patients in whom capsule colonoscopy visualizes the complete segments missed by prior incomplete standard colonoscopy.

Estimated Enrollment: 74
Study Start Date: June 2010
Estimated Study Completion Date: October 2012
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Incomplete Colonoscopy


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients that are indicated for colonoscopy, who are suspected or known to suffer from colonic diseases and had an incomplete standard colonoscopy

Inclusion Criteria:

  • Subject is >/= 18 years
  • Subject is suspected/known to suffer from large bowel disease and was clinically referred for colonoscopy.
  • Standard colonoscopy could not be performed completely in spite of adequate bowel cleansing and in the absence of a relevant colonic or rectal stenosis. Reasons for incomplete colonoscopy: adhesions, elongated colon, repeatedly forming loops, difficult procedure(time to reach the cecum >45 min), adverse reaction to sedation requiring termination of colonoscopy

Exclusion Criteria:

  • Subject has dysphagia or any swallowing disorder
  • Subject has severe congestive heart failure or renal insufficiency
  • Subject with high risk for capsule retention
  • Subject has a cardiac pacemakers or other implanted electromedical devices
  • Subject has any allergy or other contraindication to the medications used in the study
  • Subject is expected to undergo MRI examination 7 days after capsule ingestion Subject has any condition, which precludes compliance with study and/or device instructions.
  • Women who are pregnant or nursing at the time of screening and/or during the study period, or are of child bearing potential without medically acceptable methods of contraception
  • Subject suffers from life threatening conditions
  • Subject currently participating in another clinical study
  • Colonoscopy had been performed by a physician who has experience of <1000 complete colonoscopies
  • Exchange of the endoscope had been performed because complete colonoscopy was impossible with the standard endoscope
  • Time interval between incomplete colonoscopy and capsule endoscopy >30 days
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01480635

Ev. Krankenhaus Düsseldorf
Düsseldorf, Germany, 40217
Gastroenterologische Praxis
Düsseldorf, Germany, 40227
Klinikum der J.W. Goethe-Universität, Medizinische Klinik 1
Frankfurt, Germany, 60590
Bethesda Krankenhaus Bergedorf
Hamburg, Germany, 21029
Asklepios Klinik Altona
Hamburg, Germany, 22763
Klinikum der Stadt Ludwigshafen am Rhein
Ludwigshafen, Germany, 67063
Sponsors and Collaborators
Bethesda Krankenhaus
Given Imaging Ltd.
Principal Investigator: Martin Keuchel, Dr. Bethesda Krankenhaus Bergedorf, Hamburg, Germany
  More Information

Responsible Party: Bethesda Krankenhaus
ClinicalTrials.gov Identifier: NCT01480635     History of Changes
Other Study ID Numbers: PV3467 
Study First Received: October 13, 2011
Last Updated: November 28, 2011

Keywords provided by Bethesda Krankenhaus:
Incomplete Colonoscopy
Efficacy of PillCam Colon2

ClinicalTrials.gov processed this record on January 19, 2017